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Several trends are evolving that will shape the future management
of infected pancreatic necrosis (IPN) and its complications. First,
open necrosectomy is no longer considered the standard of care in
many leading centres and it is no longer considered an absolute
requirement for IPN. This has occurred during the proliferation
of minimally invasive treatments for IPN1 and the emerging evi-
dence that they result in improved outcomes.2When the Liverpool
group compared contemporaneous patients with similar demo-
graphics and pre-operative parameters who had minimal access
retroperitoneal necrosectomy or open necrosectomy, the former
had a lower morbidity, mortality and need for intensive care,
reflected in a lower rise in post-operative severity markers and
onset of new organ failure.3 We now recognize that the metabolic
impact of open necrosectomy can exceed the physiologic reserve
of patients with multiple organ dysfunction syndrome.
The second trend has been due to the realization that there
should be a delay before intervention, whenever clinically pos-
sible, and for at least 3 weeks from the onset of the disease.4
‘Staying the surgeon’s hand’ allows the maturation of infected and
necrotic lesion(s) and allows more time for intensivists to stabilize
and support patients. The placement of an external drain into
these lesions can ‘take the heat out of the fire’ by relieving pus
under pressure, stemming the systemic inflammatory response
and sometimes allowing reversal of organ dysfunction. This ‘buys
time’ before definitive intervention on a more mature lesion in an
improved patient.
The third trend was highlighted by the first randomized con-
trolled trial involving minimally invasive necrosectomy, the
PANTER trial, which compared open necrosectomy with a
‘step-up approach’ where drainage, by percutaneous or endo-
scopic means, was followed by videoscope-assisted retroperitoneal
debridement.5 The patients who had the step-up approach had a
significant decrease in the composite endpoint (major complica-
tions and/or death) and the onset of new multiple organ failure,
with fewer admissions to the intensive care unit. This study pro-
vides compelling evidence for adopting primary percutaneous
drainage (PCD) followed by minimally invasive necrosectomy in
patients with suspected IPN. There are some settings where inter-
vention by percutaneous or endoscopic drainage is not appropri-
ate in necrotizing pancreatitis, for example, retroperitoneal
haemorrhage, intestinal necrosis and duodenal/biliary obstruc-
tion, and there are occasional situations where PCD is not con-
sidered technically feasible.6
Finally, it is recognized that PCD can be the sole treatment in
some patients with IPN, avoiding an unnecessary necrosectomy
altogether. There has been extensive experience with PCD as a
secondary treatment for residual collections after open necrosec-
tomy, and an increasing experience of it to delay necrosectomy,
but there is much less experience with it as sole treatment. We do
not know whether PCD is best performed when infection is sus-
pected, when it is confirmed or when it can be delayed. Some
interventional radiologists have advocated primary PCD for some
time but widespread adoption has not occurred.7 However, recent
data suggest that this might soon change. A comprehensive sys-
tematic review found that 56% of patients, which included those
with both sterile and IPN, did not require a surgical necrosectomy
after PCD.8 There will remain debate as to the proportion of
patients who can be treated solely by PCD. The 56% from the
systematic review8 and 35% from the PANTER trial5 are likely to
be an overestimate, because of selection bias and other design
limitations, especially with the source studies. The role of sole
PCD in treating IPN needs further evaluation, but it will not go
away. The challenge is how to do it better.
One clue to improving the outcome from sole PCD comes from
the striking variation in technique revealed in the systematic
review.8 Only 5 of the 11 studies used the Seldinger technique,
narrow calibre drains were used frequently and only one study
undertook routine stepwise dilation for upsizing. The average
number of drains used for each patient was only two and the
number used at any one time was impossible to determine. In
spite of wide variation in technique there is considerable benefit
from PCD and standardization should bring further benefit. This
would likely require a more vigorous drainage approach in which
drains are exchanged routinely to avoid occlusion and upsized
routinely to facilitate egress. Larger and multiple drains would
also enable more effective irrigation, including continuous and
even pulsed methods. Questions remain as to which type of fluid
should be used for irrigation and whether it can be used actively to
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accelerate liquefaction. The development of such an ‘active or
augmented’ approach to drainage may well be the way forward.
Establishing larger diameter access ports should also allow repeat
procedures to be performed without the need for general anaes-
thesia,9 and even as an outpatient. If hospital stay can be reduced
there will be notable economic benefits from PCD.10
The trail has been blazed, traffic is increasing, but the road has
yet to be paved. Further work is required, not only in regards to
standardizing PCD techniques, but in determining ways to do it
better. The downside to PCD in this setting is that it cannot be
applied to all lesions in all patients and there is a substantial failure
rate. However, it is not the failure rate that is important but that
PCD will avoid the need for further intervention in a proportion
of patients. The challenge is to drive the proportion even higher
with more efficient and effective PCD techniques, resulting in a
decrease in hospital stay and mortality.
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